This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.

INVEGA HAFYERA - How Supplied – Storage and Handling

Last Updated: 10/01/2024

Summary

  • INVEGA HAFYERA is available as a white to off-white sterile, aqueous, extended-release suspension for gluteal intramuscular injection in dose strengths of 1,092 mg/3.5 ml and 1,560 mg/5 ml paliperidone palmitate. The kit contains a prefilled single-dose syringe and 20G, 1½-inch safety needle.1
  • The product should be shipped and stored in a horizontal position to improve the ability to resuspend this highly concentrated product. See arrows on product carton for proper orientation.1
    • Following the instructions for use in the label will result in correct resuspension of the product regardless of prior shipment or storage orientation of the product.2
  • Do not mix INVEGA HAFYERA with any other product or diluent.1
  • Please refer to local labeling for relevant information regarding storage temperatures and excursions.

References

1 Data on File. Paliperidone palmitate 6-month injection, Version 002. Janssen Research & Development, LLC; Paliperidone Palmitate CCDS; 2022.  
2 Data on File. Paliperidone Palmitate 6-month. Janssen R&D, LLC. TV-TEC 210924; 2021.